Filing Details

Accession Number:
0001562180-21-007738
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-16 21:04:36
Reporting Period:
2021-12-14
Accepted Time:
2021-12-16 21:04:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1785732 Elyse Stock C/O Biohaven Pharmaceuticals, Inc.
215 Church Street
New Haven CT 06510
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2021-12-14 3,362 $20.79 10,829 No 4 M Direct
Common Shares Acquisiton 2021-12-14 3,577 $10.82 14,406 No 4 M Direct
Common Shares Disposition 2021-12-14 6,939 $105.02 7,467 No 4 S Direct
Common Shares Acquisiton 2021-12-15 6,996 $20.79 14,463 No 4 M Direct
Common Shares Acquisiton 2021-12-15 14,923 $10.82 29,386 No 4 M Direct
Common Shares Disposition 2021-12-15 20,330 $105.43 9,056 No 4 S Direct
Common Shares Disposition 2021-12-15 1,589 $106.17 7,467 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Employee Stock Option (Right to Buy) Disposition 2021-12-14 3,362 $0.00 3,362 $20.79
Common Shares Employee Stock Option (Right to Buy) Disposition 2021-12-14 3,577 $0.00 3,577 $10.82
Common Shares Employee Stock Option (Right to Buy) Disposition 2021-12-15 6,996 $0.00 6,996 $20.79
Common Shares Employee Stock Option (Right to Buy) Disposition 2021-12-15 14,923 $0.00 14,923 $10.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,534 2027-12-06 No 4 M Direct
14,923 2027-04-05 No 4 M Direct
11,538 2027-12-06 No 4 M Direct
0 2027-04-05 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 2,187 Indirect By Spouse
Footnotes
  1. These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 - $105.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 - $105.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 - $106.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  5. The shares underlying this option vested as to 25% of the shares on December 7, 2018, the grant date, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date.
  6. The shares underlying this option vested as to 25% of the shares on April 6, 2017, the grant date, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date